{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:27:17Z","timestamp":1792682837624,"version":"4.5.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL128156"],"award-info":[{"award-number":["R01 HL128156"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL128156-08S1"],"award-info":[{"award-number":["R01 HL128156-08S1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL128156-07S2"],"award-info":[{"award-number":["R01 HL128156-07S2"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL143998"],"award-info":[{"award-number":["R01 HL143998"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["F32 HL166065"],"award-info":[{"award-number":["F32 HL166065"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K12 HL143961"],"award-info":[{"award-number":["K12 HL143961"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL128156"],"award-info":[{"award-number":["R01 HL128156"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL128156-08S1"],"award-info":[{"award-number":["R01 HL128156-08S1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL128156-07S2"],"award-info":[{"award-number":["R01 HL128156-07S2"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL143998"],"award-info":[{"award-number":["R01 HL143998"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["F32 HL166065"],"award-info":[{"award-number":["F32 HL166065"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K12 HL143961"],"award-info":[{"award-number":["K12 HL143961"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>The most common lung function abnormality in people with human immunodeficiency virus (HIV) (PWH) is a low diffusing capacity of the lung for carbon monoxide (Dl \u00a0CO), which is associated with distinct plasma biomarker patterns, increased symptom burden, and increased mortality. In PWH undergoing spirometry and Dl \u00a0CO measurement, the most common abnormality is an abnormal Dl \u00a0CO with normal spirometry (iso\u2193Dl \u00a0CO), which is associated with distinct biomarkers and increased symptom burden but whose association with mortality is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate the relationship between abnormal Dl \u00a0CO, including iso\u2193Dl \u00a0CO, and mortality in PWH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adult PWH underwent pre and postbronchodilator spirometry and single-breath Dl \u00a0CO measurements from April 2013 to January 2023. Dl \u00a0CO was categorized as normal (Dl \u00a0CO greater than or equal to the lower limit of normal [LLN]), mildly abnormal (60% predicted &amp;lt; Dl \u00a0CO &amp;lt; LLN), or moderately to severely abnormal (Dl \u00a0CO \u226460% predicted). Iso\u2193Dl \u00a0CO was defined as abnormal Dl \u00a0CO with normal spirometry (forced expiratory volume in 1 second\/forced vital capacity \u2265 LLN, forced expiratory volume in 1 second\u2009\u2265\u2009LLN, forced vital capacity \u2265 LLN). Participants\u2019 present vital status was assessed through electronic health record review and the National Death Index. Multivariable Cox proportional hazards models adjusted for age, smoking status, history of bacterial pneumonia, and CD4 count were used to estimate associations between Dl \u00a0CO and all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 241 participants, 205 (85%) were male and 26 (11%) died during follow-up of 1,055 person-years. Among 178 participants with normal spirometry, 16 (9%) died over 770 person-years. Both moderate to severe Dl \u00a0CO impairment (adjusted hazard ratio, 4.67; 95% confidence interval, 1.69\u201312.9; P\u2009=\u20090.003) and moderate to severe iso\u2193Dl \u00a0CO (adjusted hazard ratio, 11.0; 95% confidence interval, 2.20\u201355.1; P\u2009=\u20090.004) were significantly associated with increased mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Moderate to severe impairment of Dl \u00a0CO and iso\u2193Dl \u00a0CO are associated with all-cause mortality in PWH. Further studies evaluating mechanistic pathways and cause-specific mortality are warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202407-774oc","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T13:37:37Z","timestamp":1749735457000},"page":"1504-1511","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":1,"title":["Moderate to Severe Impairment of D\n                    <scp>l<\/scp>\n                    \u00a0CO and Iso\u2193D\n                    <scp>l<\/scp>\n                    \u00a0CO Are Associated with All-Cause Mortality in People with Human Immunodeficiency Virus"],"prefix":"10.1093","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9186-6712","authenticated-orcid":false,"given":"Michelle H.","family":"Zhang","sequence":"first","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Fitzpatrick","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Branchini","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6739-1120","authenticated-orcid":false,"given":"Katerina L.","family":"Byanova","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Abelman","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Feinberg","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Hunt","sequence":"additional","affiliation":[{"name":"Division of Experimental Medicine, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Biophysics, University of California, San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3888-2195","authenticated-orcid":false,"given":"Laurence","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of HIV, Infectious Diseases, and Global Medicine"},{"name":"Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"2026020300174115100_bib1","doi-asserted-by":"crossref","first-page":"18078","DOI":"10.7448\/IAS.15.6.18078","article-title":"Life expectancy of HIV-1-positive individuals approaches normal conditional on response to antiretroviral therapy: UK Collaborative HIV Cohort Study","volume":"15","author":"May","year":"2012","journal-title":"J Int AIDS Soc"},{"key":"2026020300174115100_bib2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1506816","article-title":"Initiation of antiretroviral therapy in early asymptomatic HIV infection","volume":"373","author":"Lundgren","year":"2015","journal-title":"N Engl J Med"},{"key":"2026020300174115100_bib3","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/00002030-200307250-00012","article-title":"Dramatic improvement in survival among adult Brazilian AIDS patients","volume":"17","author":"Marins","year":"2003","journal-title":"AIDS"},{"key":"2026020300174115100_bib4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/cid\/ciu869","article-title":"Comparison of risk and age at diagnosis of myocardial infarction, end-stage renal disease, and non-AIDS-defining cancer in HIV-infected versus uninfected adults","volume":"60","author":"Althoff","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2026020300174115100_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.201006-0836OC","article-title":"HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era","volume":"183","author":"Crothers","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020300174115100_bib6","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1186\/s12879-020-05593-4","article-title":"Evolution of comorbidities in people living with HIV between 2004 and 2014: cross-sectional analyses from ANRS CO3 Aquitaine cohort","volume":"20","author":"Bonnet","year":"2020","journal-title":"BMC Infect Dis"},{"key":"2026020300174115100_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/jama.2019.19775","article-title":"Comorbidities in persons with HIV: the lingering challenge","volume":"323","author":"Lerner","year":"2020","journal-title":"JAMA"},{"key":"2026020300174115100_bib8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/thoraxjnl-2011-200702","article-title":"Association between obstructive lung disease and markers of HIV infection in a high-risk cohort","volume":"67","author":"Drummond","year":"2012","journal-title":"Thorax"},{"key":"2026020300174115100_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/17476348.2021.1848556","article-title":"Chronic obstructive pulmonary disease in HIV","volume":"15","author":"Byanova","year":"2021","journal-title":"Expert Rev Respir Med"},{"key":"2026020300174115100_bib10","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1164\/rccm.200912-1858OC","article-title":"Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era","volume":"182","author":"Gingo","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020300174115100_bib11","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/thoraxjnl-2017-211079","article-title":"Airflow limitation in people living with HIV and matched uninfected controls","volume":"73","author":"Ronit","year":"2018","journal-title":"Thorax"},{"key":"2026020300174115100_bib12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s15010-012-0330-x","article-title":"Chronic obstructive pulmonary disease: an emerging comorbidity in HIV-infected patients in the HAART era?","volume":"41","author":"Madeddu","year":"2013","journal-title":"Infection"},{"key":"2026020300174115100_bib13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/hiv.12117","article-title":"Prevalence of and risk factors for pulmonary abnormalities in HIV-infected patients treated with antiretroviral therapy","volume":"15","author":"Samp\u00e9riz","year":"2014","journal-title":"HIV Med"},{"key":"2026020300174115100_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/QAD.0000000000001701","article-title":"Markers of chronic obstructive pulmonary disease are associated with mortality in people living with HIV","volume":"32","author":"Triplette","year":"2018","journal-title":"AIDS"},{"key":"2026020300174115100_bib15","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1164\/rccm.202301-0106PP","article-title":"Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary","volume":"207","author":"Agust\u00ed","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020300174115100_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/QAI.0b013e3182a9215a","article-title":"HIV infection is associated with reduced pulmonary diffusing capacity","volume":"64","author":"Crothers","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026020300174115100_bib17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/QAI.0b013e3182a9213a","article-title":"HIV infection is associated with diffusing capacity impairment in women","volume":"64","author":"Fitzpatrick","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026020300174115100_bib18","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1097\/QAD.0000000000002526","article-title":"Lung function in men with and without HIV","volume":"34","author":"Kunisaki","year":"2020","journal-title":"AIDS"},{"key":"2026020300174115100_bib19","doi-asserted-by":"crossref","first-page":"e727","DOI":"10.1093\/cid\/ciac391","article-title":"Lung function in women with and without human immunodeficiency virus","volume":"76","author":"Wang","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026020300174115100_bib20","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1097\/QAD.0000000000002846","article-title":"Markers of inflammation and immune activation are associated with lung function in a multi-center cohort of persons with HIV","volume":"35","author":"Jan","year":"2021","journal-title":"AIDS"},{"key":"2026020300174115100_bib21","doi-asserted-by":"crossref","first-page":"e0288803","DOI":"10.1371\/journal.pone.0288803","article-title":"Isolated abnormal diffusing capacity for carbon monoxide (iso\u2193DLco) is associated with increased respiratory symptom burden in people with HIV infection","volume":"18","author":"Byanova","year":"2023","journal-title":"PLoS One"},{"key":"2026020300174115100_bib22","first-page":"A5655","article-title":"Differential gene expression in immune activation and inflammatory pathways in HIV-infected persons are associated with DLCO abnormalities [abstract]","volume":"205","author":"Zhang","year":"2022"},{"key":"2026020300174115100_bib23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1513\/AnnalsATS.201606-492OC","article-title":"Decreased lung function and all-cause mortality in HIV-infected individuals","volume":"15","author":"Gingo","year":"2018","journal-title":"Ann Am Thorac Soc"},{"key":"2026020300174115100_bib24","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1513\/AnnalsATS.202204-332OC","article-title":"Pulmonary function trajectories in people with HIV: analysis of the Pittsburgh HIV Lung Cohort","volume":"19","author":"Konstantinidis","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"2026020300174115100_bib25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1513\/AnnalsATS.201807-460OC","article-title":"Lung function, coronary artery disease, and mortality in HIV","volume":"16","author":"Chandra","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"2026020300174115100_bib26","doi-asserted-by":"crossref","first-page":"1600016","DOI":"10.1183\/13993003.00016-2016","article-title":"ERS\/ATS standards for single-breath carbon monoxide uptake in the lung","volume":"49","author":"Brian","year":"2017","journal-title":"Eur Respir J"},{"key":"2026020300174115100_bib27","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026020300174115100_bib28","doi-asserted-by":"crossref","first-page":"1700010","DOI":"10.1183\/13993003.00010-2017","article-title":". Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians","volume":"50","author":"Stanojevic","year":"2017","journal-title":"Eur Respir J"},{"key":"2026020300174115100_bib29","doi-asserted-by":"crossref","first-page":"2101499","DOI":"10.1183\/13993003.01499-2021","article-title":"ERS\/ATS technical standard on interpretive strategies for routine lung function tests","volume":"60","author":"Stanojevic","year":"2022","journal-title":"Eur Respir J"},{"key":"2026020300174115100_bib30","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3\u201395-yr age range: the Global Lung Function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"key":"2026020300174115100_bib31","first-page":"1887","article-title":"Robust causal inference using directed acyclic graphs: the R package \u2018dagitty\u2019","volume":"45","author":"Textor","year":"2016","journal-title":"Int J Epidemiol"},{"key":"2026020300174115100_bib32","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/hiv.13391","article-title":"Immune restoration affects 10-year survival in people living with HIV\/AIDS","volume":"24","author":"Aksak-W\u0105s","year":"2023","journal-title":"HIV Med"},{"key":"2026020300174115100_bib33","doi-asserted-by":"crossref","first-page":"e1001194","DOI":"10.1371\/journal.pmed.1001194","article-title":"CD4 cell count and the risk of AIDS or death in HIV-infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE","volume":"9","author":"The Opportunistic Infections Project Team of the Collaboration of Observational HIVERiEiE","year":"2012","journal-title":"PLoS Med"},{"key":"2026020300174115100_bib34","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1097\/QAD.0b013e32830507f2","article-title":"Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women","volume":"22","author":"Cook","year":"2008","journal-title":"AIDS"},{"key":"2026020300174115100_bib35","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/oxfordjournals.aje.a009394","article-title":"Pulmonary function levels as predictors of mortality in a national sample of US adults","volume":"147","author":"Neas","year":"1998","journal-title":"Am J Epidemiol"},{"key":"2026020300174115100_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1513\/AnnalsATS.202203-226OC","article-title":"Diffusing capacity and mortality in chronic obstructive pulmonary disease","volume":"20","author":"Balasubramanian","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"2026020300174115100_bib37","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1164\/ajrccm.162.2.9912058","article-title":"Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons","volume":"162","author":"Morris","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"suppl 62","key":"2026020300174115100_bib38","first-page":"PA4119","article-title":"Association between diffusion capacity and endothelial function in patients with idiopathic pulmonary fibrosis [abstract]","volume":"52","author":"Castillo-Aguilar","year":"2018","journal-title":"Eur Respir J"},{"key":"2026020300174115100_bib39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fcvm.2018.00185","article-title":"HIV proteins and endothelial dysfunction: implications in cardiovascular disease","volume":"5","author":"Anand","year":"2018","journal-title":"Front Cardiovasc Med"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/22\/10\/1504\/66716545\/annalsats_22_10_1504.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/22\/10\/1504\/66716545\/annalsats_22_10_1504.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T05:17:51Z","timestamp":1770095871000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/22\/10\/1504\/8444083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":39,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,1]]},"published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202407-774oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"2024-07-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}